Literature DB >> 11161276

Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnaviruses.

Miriam Triyatni1, Peter L Ey1, Thien Tran1, Marc Le Mire1, Ming Qiao2, Christopher J Burrell2,1, Allison R Jilbert2,1.   

Abstract

The genome of an Australian strain of duck hepatitis B virus (AusDHBV) was cloned from a pool of congenitally DHBV-infected-duck serum, fully sequenced and found by phylogenetic analyses to belong to the 'Chinese' DHBV branch of the avian hepadnaviruses. Sequencing of the Pre-S/S gene of four additional AusDHBV clones demonstrated that the original clone (pBL4.8) was representative of the virus present in the pool, and a head-to-tail dimer of the clone was infectious when inoculated into newly hatched ducks. When the published sequences of 20 avian hepadnaviruses were compared, substitutions or deletions in the polymerase (POL) gene were most frequent in the 500 nt segment encoding the 'spacer' domain that overlaps with the Pre-S domain of the Pre-S/S gene in a different reading frame. In contrast, substitutions and deletions were rare within the adjacent segment that encodes the reverse transcriptase domain of the POL protein and the S domain of the envelope protein, presumably because they are more often deleterious.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161276     DOI: 10.1099/0022-1317-82-2-373

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Small DNA hairpin negatively regulates in situ priming during duck hepatitis B virus reverse transcription.

Authors:  Jeffrey W Habig; Daniel D Loeb
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Frequency of spontaneous mutations in an avian hepadnavirus infection.

Authors:  I Pult; N Abbott; Y Y Zhang; J Summers
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 3.  Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.

Authors:  Anneke Funk; Mouna Mhamdi; Hans Will; Hüseyin Sirma
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  A high level of mutation tolerance in the multifunctional sequence encoding the RNA encapsidation signal of an avian hepatitis B virus and slow evolution rate revealed by in vivo infection.

Authors:  Bernadette Schmid; Christine Rösler; Michael Nassal
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

5.  Molecular characterization of duck hepatitis B virus isolated from Hubei brown ducks.

Authors:  Quan Hu; Xiaoyong Zhang; Yangchang Lei; Zhengmao Zhang; Lu Mengji; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

6.  Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

Authors:  Wendy K Foster; Darren S Miller; Catherine A Scougall; Ieva Kotlarski; Richard J Colonno; Allison R Jilbert
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.

Authors:  Marc F Le Mire; Darren S Miller; Wendy K Foster; Christopher J Burrell; Allison R Jilbert
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Molecular characterization of duck hepatitis B virus isolates from South African ducks.

Authors:  Nomathibane P Mangisa; Heidi E Smuts; Anna Kramvis; C Wendy Linley; Michelle Skelton; Timothy J Tucker; Pauline De La M Hall; Del Kahn; Allison R Jilbert; Michael C Kew
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

9.  Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.

Authors:  Wendy K Foster; Darren S Miller; Patricia L Marion; Richard J Colonno; Ieva Kotlarski; Allison R Jilbert
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.

Authors:  Faseeha Noordeen; Andrew Vaillant; Allison R Jilbert
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.